Phase I Trial Evaluating the Safety of a Lactate Releasing Vaginal Ring for the Prophylaxis of Bacterial Vaginosis
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- University Ghent
- Enrollment
- 6
- Locations
- 1
- Primary Endpoint
- Absence/presence of visible cervicovaginal inflammation/irritation by colposcopy
Study Overview
Brief Summary
In this first-in-human volunteer phase I clinical trial, a vaginal ring that slowly releases lactic acid (racemic mixture) into the vaginal environment, will be inserted in healthy volunteering women and left in place for 7 days. The primary objective of this phase I study is to assess the safety and the tolerability of this new intravaginal delivery system.
The eventual goal of this and related studies is to develop a vaginal ring that reduces recurrences in women suffering from bacterial vaginosis, which is the commonest form of vaginal infection.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 45 Years (Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Good general physical and mental health
- •Presence of normal (lactobacilli-dominated) vaginal microbiota
- •Prepared to take oral contraception during the study
Exclusion Criteria
- •Pregnancy
- •Lactation
- •Systemic disease
- •Menopause
- •Recent use of antibiotics (<1 week before entering the study)
- •Recent use of intravaginal products or devices (<1 week before enrolment)
- •Presence of vaginal infection
Arms & Interventions
Vaginal Ring
A vaginal ring that slowly releases lactic acid (racemic mixture) into the vaginal environment, will be inserted in healthy volunteering women and left in place for 7 days.
Intervention: Vaginal ring releasing lactic acid (racemic mixture) (Device)
Outcomes
Primary Outcomes
Absence/presence of visible cervicovaginal inflammation/irritation by colposcopy
Time Frame: 7 days after insertion
Absence/presence of visible cervicovaginal inflammation/irritation by colposcopy
Time Frame: 1 hour after insertion
Absence/presence of visible cervicovaginal inflammation/irritation by colposcopy
Time Frame: 2 hours after insertion
Absence/presence of visible cervicovaginal inflammation/irritation by colposcopy
Time Frame: 4 hours after insertion
Absence/presence of visible cervicovaginal inflammation/irritation by colposcopy
Time Frame: 8 hours after insertion
Absence/presence of visible cervicovaginal inflammation/irritation by colposcopy
Time Frame: 24 hours after insertion
Secondary Outcomes
- Assessment of vaginal pH(each 30 minutes for 4 hours after insertion, and then each 60 minutes for the next 4 hours)
